Standout Papers
- Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation (1995)
- Infusion of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus–Induced Lymphoma in Allogeneic Transplant Recipients (1998)
- Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients (2009)
Immediate Impact
7 by Nobel laureates 32 from Science/Nature 86 standout
Citing Papers
Epstein-Barr virus: Biology and clinical disease
2022 Standout
Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies
2021 Standout
Works of Colton A. Smith being referenced
Antibodies Predict Pegaspargase Allergic Reactions and Failure of Rechallenge
2019
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
2009 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Colton A. Smith | 2380 | 1347 | 1331 | 17 | 3.4k | |
| M. Helen Huls | 3795 | 1009 | 2378 | 48 | 4.8k | |
| Joyce D. Fingeroth | 1750 | 978 | 1145 | 45 | 3.1k | |
| B. G. Achong | 2912 | 1436 | 831 | 38 | 4.0k | |
| P L Amlot | 1802 | 1467 | 2325 | 100 | 5.9k | |
| Dulce Soler | 1569 | 639 | 3555 | 39 | 5.3k | |
| Bianca Santomasso | 3070 | 398 | 747 | 44 | 3.6k | |
| Brigitte Sénéchal | 2213 | 425 | 1595 | 43 | 3.9k | |
| Catherine Y. Ng | 3428 | 1696 | 1741 | 60 | 6.3k | |
| Margaret Callan | 1301 | 1303 | 3079 | 43 | 4.1k | |
| Robert W. Atchison | 1664 | 1041 | 319 | 50 | 3.6k |
All Works
Loading papers...